Status:
COMPLETED
Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
65+ years
Brief Summary
To assess the prevalence of all (prevalent and paroxysmal) undiagnosed atrial fibrillation (AF) in a Japanese population with a moderate-to-high risk of stroke
Eligibility Criteria
Inclusion
- Age ≥ 65 and one or more of the following: hypertension, prior stroke or transient ischemic attack, congestive heart failure, diabetes mellitus, and/or vascular disease
Exclusion
- Age \< 65 years, individuals with AF or a history of AF, or individuals taking anti-arrhythmic drugs
- Other protocol defined inclusion/exclusion criteria could apply
Key Trial Info
Start Date :
September 29 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 23 2019
Estimated Enrollment :
1316 Patients enrolled
Trial Details
Trial ID
NCT03313167
Start Date
September 29 2017
End Date
May 23 2019
Last Update
August 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Itabashi-ku, Tokyo, Japan, 173-0003